Hints and tips:
Related Special Reports
...Brussels has accused Illumina of using “delay tactics” to prevent a speedy ruling on whether the world’s biggest gene sequencing company should be forced to divest cancer test developer Grail....
...The world’s largest gene sequencing company said on Tuesday that Thaysen, who previously led Agilent’s life sciences and applied markets group, would begin as chief executive on September 25....
...This followed the ousting of chairman John Thompson in a shareholder vote in May....
...Gary Guthart told the Financial Times there was depth on the board and management of the world’s biggest gene sequencing company beyond the two executives, who had been targeted in a proxy battle waged by...
...The company faces growing competition from several new entrants and Chinese gene sequencing company MGI....
...The world’s largest gene-sequencing company said on Tuesday that Thaysen, who previously ran Agilent Technologies’ life sciences and applied markets group, would begin as chief executive on September 25....
...And two, he wanted to obtain three seats on Illumina’s board, including the seats of Illumina CEO Francis DeSouza and Illumina’s chair John Thompson....
...Influential proxy advisers Glass Lewis have recommended investors withhold their support for the reappointment of Illumina chief executive Francis deSouza and chair John Thompson to the board of the company...
...Influential proxy adviser Glass Lewis has urged investors to vote against the reappointment of the chief executive and chair of Illumina, the world’s largest gene sequencing company, saying the pair have...
...Andrew Teno, Icahn’s nominee for a board seat at the world’s biggest gene sequencing company, won a shareholder vote at the company’s annual meeting on Thursday, while Thompson was unseated....
...The down-on-his-luck corporate raider pulled off a partial victory in a proxy showdown against gene sequencing group Illumina on Thursday when shareholders voted to oust its chair, John Thompson, and approve...
...While the results of the tests can “satisfy initial curiosity” in those who take them, they also tend to “open more questions”, said Scott Fisher, host of the Extreme Genes radio show and podcast....
...Thompson is a fine songwriter, but his greatest strength is his voice — his mother’s genes seem to have been prevalent in that department — and it has seldom sounded so rich and resonant, at times crackling...
...Bad genes: Ancestry.com’s polarising debt deal What’s Blackstone been up to since it clinched that $4.7bn deal to acquire a 75 per cent stake in Ancestry.com, the website where people can pay to map out...
...Keith Thompson, chief executive of the UK’s Cell and Gene Therapy Catapult, likes to joke that he started out with “a mobile phone and a big cheque”....
...The Rosewater Insurrection , by Tade Thompson, Orbit, RRP£8.99 The sequel to Thompson’s stellar 2018 debut Rosewater continues to explore the titular town which has grown up around a huge alien-built dome...
...He claims Prof Toumazou pressured him to commercialise his work on next-generation gene sequencing and misled him into applying for patents based on his research for Mr Toumazou’s company as a requirement...
...In 2013, the Court ruled on whether Myriad Genetics could be the exclusive provider of tests used to screen patients for cancer, and whether human genes could be patented — the underlying legal point....
...“I have the hobby gene but my hobby [now] is collecting good businesses.”...
...“This is a completely new arm of medicine and we believe it’s going to be the next big thing,” says Keith Thompson, chief executive of the UK’s Cell and Gene Therapy Catapult, which supports research and...
...Cousins, chief executive of FTSE 100 caterer Compass Group and a City of London company turnround expert, died in an aircraft crash in Australia that also killed four of his close family members, writes Rod Thompson...
...“It’s great that it shows ambition, which we can turn into real growth,” said Keith Thompson, chief executive of the Cell and Gene Therapy Catapult....
...“It is not just about money,” says Keith Thompson, chief executive of the UK Cell and Gene Therapy Catapult, an initiative to promote human cell manufacturing....
...Women sprinters follow the pattern: most recently, Elaine Thompson picked up gold in the women’s 100m in Rio on Saturday....
...CEO, Cell and Gene Therapy Catapult and BIA Board Dr Darrin Disley CEO and President, Horizon Discovery and BIA Board Dr Patrick Vallance President, Pharmaceuticals R&D, GSK Dr Kevin Cox CEO, Imanova...
International Edition